The global BFS syringes market is predicted to exceed a valuation of US$ 878.48 million in 2023. Sales in the BFS syringes market are expected to propel at 9.4% CAGR between 2023 and 2033. As per the study, the top 3 countries are estimated to hold around 35 to 40% of the market in 2023.
Top Market Highlights:
| Attributes | Key Insights |
|---|---|
| BFS Syringes Market Size (2023) | US$ 878.48 million |
| Projected Market Size (2033F) | US$ 2,158.46 million |
| Value CAGR (2023 to 2033) | 9.4% |
| Top 3 Countries Market Share | 35-40% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the global BFS syringes market secured a CAGR of 8.7% over the historical period from 2018 to 2022 and the market reached US$ 803 million by the end of 2022.
The market for BFS syringes is projected to expand at a significant pace over the forecast period. Blow-fill-seal (BFS) is a sterilized technology utilized for packaging and automated process and is increasingly being adopted by the aseptic packaging industry.
The benefit of blow-fill-seal technology is that it packages in single dosage form, reducing the risk of errors and contamination. In addition, it is used for packaging diagnostic kits, medical devices, tablets, syringes, vaccines, and others. The technology known as blow fill seal (BFS) is used to fill containers with a range of liquids in small and big volumes.
The BFS technology has been approved by FDA (Food and Drug Administration) approval for use in making pharmaceutical and healthcare items using a superior aseptic processing method. Also, the method combines several procedures, such as extrusion, molding, sealing, and filling in a single step without the use of outside assistance.
The fully automatic BFS technology's filling and sealing procedure offers a high level of product and process reliability with precision filling. To cater to this rising demand, manufacturers are expanding their production capacities along with target markets. Backed by these aforementioned factors, the BFS syringes market is expected to increase at a CAGR of 9.4% over the next decade.
Increasing Demand for Aseptic Packaging Fuelling BFS Syringes Sales
BFS syringes offer a sterile solution and satisfy the requirement for aseptic conditions with the advent of automation in the packaging industry. High accuracy is provided by aseptic packaging employing BFS syringes technology regarding the number of clean products packed per minute.
Syringes are manufactured, filled, and sealed utilizing automated BFS technology in a single process. BFS machinery is suited for single-use dose aseptic and sterilized syringes as it reduces the possibility of extraneous contamination.
BFS technology is frequently employed for the aseptic packing of respiratory, ophthalmic, oral, and pre-filled syringes & injectable medications. These goods do not need refrigeration, making them convenient for buyers and reasonably priced for sellers.
Development in Pharmaceutical Sector Creating Growth Opportunities
Advanced sterilizing techniques are used by leading pharmaceutical manufacturers to reduce operator involvement and the chance of contamination while packaging liquid medications. It is a preferred technology for drug packaging as it offers flexible versatility in packaging design, cost-effectiveness, sterility, and limited component inventory.
The packaging of a wide range of containers is now possible. It is due to the developments in the BFS system, including vials with inserted tips or caps, twist-off re-closable vials, eyewash and contact lens solution bottles, multi-dose use bottles, unit dose syringes & injectables, and sports drink bottles.
The pharmaceutical sector is witnessing an increase in demand for sophisticated aseptic packaging, such as syringes, bottles, vials, and ampoules employing the BFS technology. The market for BFS syringes is therefore expected to expand significantly as a result of the rise in demand for these product categories.
Principal Consultant
The United States BFS syringe market is anticipated to create an incremental opportunity of US$ 248 million from 2023 to 2033 and is estimated to expand 2.3x the current market value by the end of 2033. According to the Centers for Disease Control and Prevention (CDC), around 76% of the United States population have received at least one dose of COVID vaccine until 8th February 2022.
The demand in the market is projected to spur with the advent of automation in the packaging industry and demand for aseptic packaging in the United States to reduce the risk of contamination. As per FMI, backed by these factors, demand for modified BFS technology syringes is predicted to surge over the forecast period
Germany is a top-tier country concerning pharmaceutical producers. The company also exports an extensive range of medicinal products the world over. Germany is forecasted to sustain its position as a top market for BSF syringe manufacturers. This is further highlighted by the fact that pharmaceutical packaging leaders have set their bases in the country, and they show a penchant for blow-fill-seal technology to sterilize injectable packaging and ampoules.
BFS technique has recently seen high use in the pharmaceutical industry to serve parental preparation with relatively less interference from human beings. This technology is seen as a superior method for aseptic filling of parental preparation by multiple regulatory bodies like the USA Food and Drug Administration (FDA). It is further deployed to fill eye drops, inhalation, infusions, and other parental preparations.
Several advantages of BFS syringes, like low operating cost, flexible packaging design, high degree of sterility, low requirement of laborers, and restricted component inventory, are factored in by pharmaceutical packaging firms.
Injectable packaging has remained the central focus of companies operating in Europe, which is shooting up the market growth trajectory.
The deployment of blow-fill-seal (BFS) technology is surging in the pharmaceutical sector due to the surging demand for advanced aseptic packaging like vials, bottles, ampoules, and pre-filled syringes.
Advances in BFS technology are facilitating the packaging of a great variety of containers like twist-off & re-closeable vials, vials with inserted caps/tips, eyewash & contact lens solution bottles, multi-dose use bottles, electrolyte & sports drinks bottles, and unit dose pre-filled syringes & injectable.
According to FMI, demand in India is projected to expand at a CAGR of 10.9% from 2023 to 2033. Rising vaccination consumption in India is predicted to improve the sales of syringes. Also, the high consumption of vaccines has led the key syringes manufacturer to increase their production capacity.
As per the Hindustan Syringes & Medical Devices Ltd (HMD), the manufacturer of the syringes in India achieved the target of producing over 1 billion syringes for COVID vaccination in August 2021.
Low-density polyethylene (LDPE), high-density polyethylene (HDPE), and polypropylene (PP) are the polymers most frequently utilized in BFS syringes. As it can be extruded at a low temperature than HDPE or PP, LDPE is frequently used for containers for large-molecule medications or vaccinations.
A low processing temperature makes it simple to get the right surface temperature for filling. Since PP can resist great temperatures during the terminal sterilization procedure, it is extensively used for pharmaceuticals that need to be terminally sterilized.
The flexibility of the packaging is important when it comes to the material and for this PP material is preferred as one of the best choices. They have a unique attachment to the extruder which can allow the mixing of the quantity of the measured colorant. Hence, polypropylene (PE) is expected to generate a CAGR of 9.1% from 2023 to 2033.
As per FMI, leading pharmaceutical producers, use cutting-edge sterilizing technology to reduce errors and contamination. It is a preferred technology for drug packaging as blow-fill-seal (BFS) technology offers safe and sterile packaging. With the increasing demand for aseptic packaging in the healthcare sector, leading organizations are using such syringes employing the blow-fill-seal (BFS) technology.
The syringes used in healthcare allow to reduce the contamination risk and error of dosage. It also prevents the reuse possibility so that no cross-infection takes place. However, due to the rising demand in pharmaceutical and healthcare segments, it is expected to generate an incremental opportunity of more than US$ 770 million by 2033 for the BFS syringes market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key players operating in the BFS syringes market are adopting various mergers and acquisitions to gain a competitive edge in the industry. They are also focusing on new product launches and aseptic packaging to expand their customer base.
Key players are collaborating with pharmaceutical players to offer contract manufacturing services for prefilled syringes, injectables, and ampoules. Key strategies that have remained central to the growth of technology providers include capacity expansion, upgrading, supplementing production, and enhancing operational efficiency.
Collaboration is another go-to strategy implemented by manufacturers vying for a large geographical presence.
Recent Developments
The healthcare industry’s focus on cost-effectiveness and dosage accuracy has led to innovations in syringe technology. Blow-fill-seal (BFS) syringes are transforming how syringes are packaged and administered.
Leading syringe manufacturers are now steadily switching to BFS technology, and prominent among these manufacturers is Shanghai IVEN Pharmatech Engineering Co. Ltd. The company has a strong presence not only in the BFS syringe technology but also in other healthcare machines and devices such as peritoneal dialysis solutions, vacuum blood collection tubes, syrup washing filling capping, and virus sampling tubes.
Nipro, another leading BFS syringe manufacturer, has a strong focus on consolidating its position through innovation and research, and development. For instance, during the coronavirus pandemic, the company introduced two disposable Dosesaver vaccines that improved the yield of shots considerably. Traditional syringes can administer a shot of 5 shots, whereas the Dosesaver vaccines deliver up to 7 shots.
Nipro is expanding its manufacturing capacity by opening up new units, especially in the Asia Pacific region. For instance, the company has a 150 thousand square meter big facility in Thailand that employs over 7,000 workers. In addition to its strong focus on innovation and technology, Nipro is also committed to sustainability efforts.
Nipro has a goal of reducing its greenhouse gas emissions by 46% by 2030. The company has also installed a 1.50 megawatts solar power generation platform that is capable of generating up to 3.4 MW of power. The company has over 30 factories all over the globe, and it plans to open new units as demand for various types of healthcare devices grows.
A key area of concern for syringe manufacturers is the wear and tear caused due to the friction between syringes and machine parts. To solve this longstanding issue, many companies are focusing on research and development, and innovation.
For instance:
Mergers and acquisitions are a key part of Brevetti’s overall business strategy. The company is boosting its area of expertise through mergers and acquisitions with companies that have the technical know-how. For instance, the company announced the acquisition of Criterion AI in August 2020 to specialize in image-based learning.
Brevetti also acquired Sintech Srl in November 2020 a company specializing in automated machinery. The acquisition is likely to give Brevetti great control over automation and robotics.
| Attributes | Details |
|---|---|
| Estimated Market Size (2023) | US$ 878.48 million |
| Projected Market Size (2033F) | US$ 2,158.46 million |
| Growth Rate | CAGR of 9.4% from 2023 to 2033 |
| Base Year of Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | Capacity, Material Type, End Use, Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | IVEN Pharmatech Engineering Co., Ltd.; Brevetti Angela S.R.L; OPTIMA Packaging Group GmbH; Vanrx, AST, Inc; B. Braun Melsungen; Nipro; Takeda Pharmaceuticals International AG; Nephron Pharmaceuticals Corporation; Horizon Pharmaceutical Inc; Recipharm AB; Laboratorios SALVAT, S.A; The Ritedose Corporation; Unicep Packaging, LLC; Pharmapack Co. Ltd; Amanta Healthcare Ltd.; Automatic Liquid Packaging Solutions LLC; Asept Pak, Inc; SIFI Spa; Unither Pharmaceuticals SAS; LyondellBasell Industries N.V. |
From 2018 to 2022, the global market exhibited 8.7% CAGR.
Growing demand in the healthcare and cosmetics industry is the growth driver.
Asept Pak, Inc., SIFI Spa, and Nipro are the market players.
The United States has the dominant market share.
Development in the pharmaceutical sector creates growth opportunities.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Introduction / Key Findings
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity, 2023 to 2033
6.3.1. 0.5-1 ml
6.3.2. 1-3 ml
6.3.3. Above 3 ml
6.4. Y-o-Y Growth Trend Analysis By Capacity, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Capacity, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material Type, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material Type, 2023 to 2033
7.3.1. Polypropylene (PP)
7.3.2. Polyvinyl Chloride (PVC)
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By Material Type, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Material Type, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033
8.3.1. Pharmaceuticals and Healthcare
8.3.2. Personal Care and Cosmetics
8.3.3. Others
8.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. South Asia and Pacific
9.3.6. East Asia
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Capacity
10.2.3. By Material Type
10.2.4. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Capacity
10.3.3. By Material Type
10.3.4. By End Use
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Capacity
11.2.3. By Material Type
11.2.4. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Capacity
11.3.3. By Material Type
11.3.4. By End Use
11.4. Key Takeaways
12. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. UK
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Western Europe
12.2.2. By Capacity
12.2.3. By Material Type
12.2.4. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Capacity
12.3.3. By Material Type
12.3.4. By End Use
12.4. Key Takeaways
13. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Poland
13.2.1.2. Russia
13.2.1.3. Czech Republic
13.2.1.4. Romania
13.2.1.5. Rest of Eastern Europe
13.2.2. By Capacity
13.2.3. By Material Type
13.2.4. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Capacity
13.3.3. By Material Type
13.3.4. By End Use
13.4. Key Takeaways
14. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. India
14.2.1.2. Bangladesh
14.2.1.3. Australia
14.2.1.4. New Zealand
14.2.1.5. Rest of South Asia and Pacific
14.2.2. By Capacity
14.2.3. By Material Type
14.2.4. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Capacity
14.3.3. By Material Type
14.3.4. By End Use
14.4. Key Takeaways
15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. China
15.2.1.2. Japan
15.2.1.3. South Korea
15.2.2. By Capacity
15.2.3. By Material Type
15.2.4. By End Use
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Capacity
15.3.3. By Material Type
15.3.4. By End Use
15.4. Key Takeaways
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Capacity
16.2.3. By Material Type
16.2.4. By End Use
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Capacity
16.3.3. By Material Type
16.3.4. By End Use
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.2. 17.1.2.2. By Capacity
17.3. 17.1.2.3. By Material Type
17.4. 17.1.2.4. By End Use
17.5. Canada
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.6. 17.2.2.2. By Capacity
17.7. 17.2.2.3. By Material Type
17.8. 17.2.2.4. By End Use
17.9. Brazil
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.10. 17.3.2.2. By Capacity
17.11. 17.3.2.3. By Material Type
17.12. 17.3.2.4. By End Use
17.13. Mexico
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.14. 17.4.2.2. By Capacity
17.15. 17.4.2.3. By Material Type
17.16. 17.4.2.4. By End Use
17.17. Germany
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.18. 17.5.2.2. By Capacity
17.19. 17.5.2.3. By Material Type
17.20. 17.5.2.4. By End Use
17.21. UK
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.22. 17.6.2.2. By Capacity
17.23. 17.6.2.3. By Material Type
17.24. 17.6.2.4. By End Use
17.25. France
17.25.1. Pricing Analysis
17.25.2. Market Share Analysis, 2022
17.26. 17.7.2.2. By Capacity
17.27. 17.7.2.3. By Material Type
17.28. 17.7.2.4. By End Use
17.29. Spain
17.29.1. Pricing Analysis
17.29.2. Market Share Analysis, 2022
17.30. 17.8.2.2. By Capacity
17.31. 17.8.2.3. By Material Type
17.32. 17.8.2.4. By End Use
17.33. Italy
17.33.1. Pricing Analysis
17.33.2. Market Share Analysis, 2022
17.34. 17.9.2.2. By Capacity
17.35. 17.9.2.3. By Material Type
17.36. 17.9.2.4. By End Use
17.37. Poland
17.37.1. Pricing Analysis
17.37.2. Market Share Analysis, 2022
17.38. 17.10.2.2. By Capacity
17.39. 17.10.2.3. By Material Type
17.40. 17.10.2.4. By End Use
17.41. Russia
17.41.1. Pricing Analysis
17.41.2. Market Share Analysis, 2022
17.42. 17.11.2.2. By Capacity
17.43. 17.11.2.3. By Material Type
17.44. 17.11.2.4. By End Use
17.45. Czech Republic
17.45.1. Pricing Analysis
17.45.2. Market Share Analysis, 2022
17.46. 17.12.2.2. By Capacity
17.47. 17.12.2.3. By Material Type
17.48. 17.12.2.4. By End Use
17.49. Romania
17.49.1. Pricing Analysis
17.49.2. Market Share Analysis, 2022
17.50. 17.13.2.2. By Capacity
17.51. 17.13.2.3. By Material Type
17.52. 17.13.2.4. By End Use
17.53. India
17.53.1. Pricing Analysis
17.53.2. Market Share Analysis, 2022
17.54. 17.14.2.2. By Capacity
17.55. 17.14.2.3. By Material Type
17.56. 17.14.2.4. By End Use
17.57. Bangladesh
17.57.1. Pricing Analysis
17.57.2. Market Share Analysis, 2022
17.58. 17.15.2.2. By Capacity
17.59. 17.15.2.3. By Material Type
17.60. 17.15.2.4. By End Use
17.61. Australia
17.61.1. Pricing Analysis
17.61.2. Market Share Analysis, 2022
17.62. 17.16.2.2. By Capacity
17.63. 17.16.2.3. By Material Type
17.64. 17.16.2.4. By End Use
17.65. New Zealand
17.65.1. Pricing Analysis
17.65.2. Market Share Analysis, 2022
17.66. 17.17.2.2. By Capacity
17.67. 17.17.2.3. By Material Type
17.68. 17.17.2.4. By End Use
17.69. China
17.69.1. Pricing Analysis
17.69.2. Market Share Analysis, 2022
17.70. 17.18.2.2. By Capacity
17.71. 17.18.2.3. By Material Type
17.72. 17.18.2.4. By End Use
17.73. Japan
17.73.1. Pricing Analysis
17.73.2. Market Share Analysis, 2022
17.74. 17.19.2.2. By Capacity
17.75. 17.19.2.3. By Material Type
17.76. 17.19.2.4. By End Use
17.77. South Korea
17.77.1. Pricing Analysis
17.77.2. Market Share Analysis, 2022
17.78. 17.20.2.2. By Capacity
17.79. 17.20.2.3. By Material Type
17.80. 17.20.2.4. By End Use
17.81. GCC Countries
17.81.1. Pricing Analysis
17.81.2. Market Share Analysis, 2022
17.82. 17.21.2.2. By Capacity
17.83. 17.21.2.3. By Material Type
17.84. 17.21.2.4. By End Use
17.85. South Africa
17.85.1. Pricing Analysis
17.85.2. Market Share Analysis, 2022
17.86. 17.22.2.2. By Capacity
17.87. 17.22.2.3. By Material Type
17.88. 17.22.2.4. By End Use
17.89. Israel
17.89.1. Pricing Analysis
17.89.2. Market Share Analysis, 2022
17.90. 17.23.2.2. By Capacity
17.91. 17.23.2.3. By Material Type
17.92. 17.23.2.4. By End Use
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Capacity
18.3.3. By Material Type
18.3.4. By End Use
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. IVEN Pharmatech Engineering Co., Ltd.
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.1.5.2. Product Strategy
19.1.1.5.3. Channel Strategy
19.1.2. Brevetti Angela S.R.L
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.2.5.2. Product Strategy
19.1.2.5.3. Channel Strategy
19.1.3. OPTIMA Packaging Group GmbH
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.3.5.2. Product Strategy
19.1.3.5.3. Channel Strategy
19.1.4. Vanrx, AST, Inc
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.4.5.2. Product Strategy
19.1.4.5.3. Channel Strategy
19.1.5. B. Braun Melsungen
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.5.5.2. Product Strategy
19.1.5.5.3. Channel Strategy
19.1.6. Nipro
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.6.5.2. Product Strategy
19.1.6.5.3. Channel Strategy
19.1.7. Takeda Pharmaceuticals International AG
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.7.5.2. Product Strategy
19.1.7.5.3. Channel Strategy
19.1.8. Nephron Pharmaceuticals Corporation
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.8.5.2. Product Strategy
19.1.8.5.3. Channel Strategy
19.1.9. Horizon Pharmaceutical Inc
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.9.5.2. Product Strategy
19.1.9.5.3. Channel Strategy
19.1.10. Recipharm AB
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
19.1.10.5.2. Product Strategy
19.1.10.5.3. Channel Strategy
19.1.11. Laboratorios SALVAT, S.A
19.1.11.1. Overview
19.1.11.2. Product Portfolio
19.1.11.3. Profitability by Market Segments
19.1.11.4. Sales Footprint
19.1.11.5. Strategy Overview
19.1.11.5.1. Marketing Strategy
19.1.11.5.2. Product Strategy
19.1.11.5.3. Channel Strategy
19.1.12. The Ritedose Corporation
19.1.12.1. Overview
19.1.12.2. Product Portfolio
19.1.12.3. Profitability by Market Segments
19.1.12.4. Sales Footprint
19.1.12.5. Strategy Overview
19.1.12.5.1. Marketing Strategy
19.1.12.5.2. Product Strategy
19.1.12.5.3. Channel Strategy
19.1.13. Unicep Packaging, LLC
19.1.13.1. Overview
19.1.13.2. Product Portfolio
19.1.13.3. Profitability by Market Segments
19.1.13.4. Sales Footprint
19.1.13.5. Strategy Overview
19.1.13.5.1. Marketing Strategy
19.1.13.5.2. Product Strategy
19.1.13.5.3. Channel Strategy
19.1.14. Pharmapack Co. Ltd
19.1.14.1. Overview
19.1.14.2. Product Portfolio
19.1.14.3. Profitability by Market Segments
19.1.14.4. Sales Footprint
19.1.14.5. Strategy Overview
19.1.14.5.1. Marketing Strategy
19.1.14.5.2. Product Strategy
19.1.14.5.3. Channel Strategy
19.1.15. Amanta Healthcare Ltd.
19.1.15.1. Overview
19.1.15.2. Product Portfolio
19.1.15.3. Profitability by Market Segments
19.1.15.4. Sales Footprint
19.1.15.5. Strategy Overview
19.1.15.5.1. Marketing Strategy
19.1.15.5.2. Product Strategy
19.1.15.5.3. Channel Strategy
19.1.16. Automatic Liquid Packaging Solutions LLC
19.1.16.1. Overview
19.1.16.2. Product Portfolio
19.1.16.3. Profitability by Market Segments
19.1.16.4. Sales Footprint
19.1.16.5. Strategy Overview
19.1.16.5.1. Marketing Strategy
19.1.16.5.2. Product Strategy
19.1.16.5.3. Channel Strategy
19.1.17. Asept Pak, Inc
19.1.17.1. Overview
19.1.17.2. Product Portfolio
19.1.17.3. Profitability by Market Segments
19.1.17.4. Sales Footprint
19.1.17.5. Strategy Overview
19.1.17.5.1. Marketing Strategy
19.1.17.5.2. Product Strategy
19.1.17.5.3. Channel Strategy
19.1.18. SIFI Spa
19.1.18.1. Overview
19.1.18.2. Product Portfolio
19.1.18.3. Profitability by Market Segments
19.1.18.4. Sales Footprint
19.1.18.5. Strategy Overview
19.1.18.5.1. Marketing Strategy
19.1.18.5.2. Product Strategy
19.1.18.5.3. Channel Strategy
19.1.19. Value (US$ Million) & Volume (Units)her Pharmaceuticals SAS
19.1.19.1. Overview
19.1.19.2. Product Portfolio
19.1.19.3. Profitability by Market Segments
19.1.19.4. Sales Footprint
19.1.19.5. Strategy Overview
19.1.19.5.1. Marketing Strategy
19.1.19.5.2. Product Strategy
19.1.19.5.3. Channel Strategy
19.1.20. LyondellBasell Industries N.V
19.1.20.1. Overview
19.1.20.2. Product Portfolio
19.1.20.3. Profitability by Market Segments
19.1.20.4. Sales Footprint
19.1.20.5. Strategy Overview
19.1.20.5.1. Marketing Strategy
19.1.20.5.2. Product Strategy
19.1.20.5.3. Channel Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Packaging Insights
View Reports
BFS Syringes Market
